News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Bishoy Morris Faltas: AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
Collage photo of Bishoy Morris Faltas and Yan Leyfman
Mar 30, 2025, 21:29

Bishoy Morris Faltas: AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

Bishoy Morris Faltas, Chief Research Officer at Weill Cornell Medicine, shared a post on LinkedIn:

“Excited to share our new paper in collaboration with Fei Wang to develop a cutting-edge AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in the S1314 randomized clinical trial.

Full X-plainer here.”

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post by Bishoy Morris Faltas, adding:

“Innovative approach to utilize AI. Congratulations to Dr. Bishoy Morris Faltas and team of Weill Cornell Medicine.”

“Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning”

Authors: Zilong Bai et al.

Bishoy Morris Faltas: AI model that predicts response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

Bishoy Morris Faltas bladder cancer cancer chemotherapy Fei Wang OncoDaily Oncology Weill Cornell Medicine Yan Leyfman
Special Coverage
Blog
Jun 23, 2025, 18:55
Elvina Almuradova: What Comes After CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer?
Blog
Jun 23, 2025, 18:11
Wafaa M Rashed: The Countdown Begins for Our Upcoming PAPERI Webinar Series session
Positive
Jun 23, 2025, 17:34
Jasmine Kamboj: Enjoying the Support of Senator Klobuchar’s Office on Many Levels
Blog
Jun 23, 2025, 17:25
Dato' Dr Saunthari Somasundaram: The National Cancer Congress 2025 Has Been Nothing Short of Inspiring
Career
Jun 23, 2025, 17:16
Mercy Sopuruchi Agu Has Been Appointed Patient Navigator and Fundraising Lead at Project PINK BLUE
Blog
Jun 23, 2025, 17:07
Sebastian Szmit: Proud of My Team at ESC Cardio Oncology 2025
Positive
Jun 23, 2025, 16:55
Paul Hakimata: How Memorial Healthcare System is Becoming a Destination for Cancer Care
Science
Jun 23, 2025, 16:36
New Research on Targeted Axillary Radiation in Early Breast Cancer by Ahmed Orabi et al.
Science
Jun 23, 2025, 15:18
Myeloma Paper of the Day, June 23rd, suggested by Robert Orlowski
Oncolibrary
Jun 23, 2025, 13:51
Press Release: Zanzalintinib Plus Atezolizumab Improves Survival in Refractory Metastatic Colorectal Cancer: STELLAR-303 Results
Insight
Jun 23, 2025, 11:20
Goutham Sunny Highlighted PANOVA-3 Phase III Trial on TTFields Plus Chemotherapy in Locally Advanced Pancreatic Cancer
Insight
Jun 23, 2025, 11:18
Zihai Li: Are NK Cells Friends or Foes In Cancer Immunotherapy?